| 产品名称 | Peptides EP11293_1 | HPV 16/18 E7 11-20 (HLA-A*02:01) |
|---|---|
| 目录号 | EP11293_1 |
| 别名 | HPV 16/18 E7 11-20 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP11293_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP11293_1 | HPV 16/18 E7 11-20 (HLA-A*02:01)
品名:HPV 16/18 E7 11-20 (HLA-A*02:01)
货号:EP11293_1
规格:1 mg; 5 mg
品牌:Peptides.de
产品描述
YMLDLQPETT is a linear epitope spanning amino acids 11 to 20 of the E7 oncoproteins from Human papillomavirus type 16 (HPV-16, UniProt: P03129) and type 18 (HPV-18, UniProt: P06788), both high-risk, oncogenic HPV types. The peptide listed under the epitope ID 75075. The peptide is presented by HLA-A*02:01, a common MHC class I allele, and has been extensively validated for its immunogenic potential. It has been extensively tested in T cell assays, B cell assays, and MHC binding assays, highlighting its broad application in HPV-specific immunity studies and vaccine research. The E7 protein plays a pivotal role in HPV-mediated carcinogenesis by disrupting immune recognition pathways. Peptides derived from this region, such as YMLDLQPETT, are of particular interest for T cell-based immunotherapies. This peptide is available from stock and ready for immediate shipping to support your research needs.
| Protein | Protein E7 |
| Species | HPV 16, HPV 18 |
| Application | Flow Cytometry |
| Indication | Infectious disease, Cancer |